TotalMarketCap

Rigel Pharmaceuticals

RIGLNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$848.066 M

$45.40 -11.48%

Close of 6 Nov 2026

As of 6 Nov 2026, Rigel Pharmaceuticals (RIGL) has a market capitalization of $848.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$294.3M

#2124 by revenue

Earnings

$367.0M

#749 by earnings

Shares outstanding

18,829,972

Latest filing cover page

P/E ratio

2.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #153InventivaIVA$857.7M
  2. #154City TherapeuticsCTY$855.1M
  3. #155Rigel PharmaceuticalsRIGL$848.1M
  4. #156Syndax PharmaceuticalsSNDX$842.8M
  5. #157Corvus PharmaceuticalsCRVS$821.0M

What if Rigel Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,511,621

Per share 33,296× higher

Bitcoin $1.53T

$81,791.18

Per share 1,802× higher

Apple $5.02T

$268,512.80

Per share 5,914× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Rigel Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.